Gilead Sciences, Inc. · NASDAQ:GILD
O'Day Daniel Patrick sold 30,881 Gilead Sciences, Inc. shares (Form 4)
Traded Oct 30 to Nov 2, 2026 · Filed Nov 2, 2026
From Oct 30 to Nov 2, 2026, O'Day Daniel Patrick (Director, Chairman & CEO) sold 30,881 Gilead Sciences, Inc. shares at an average US$172.57 for US$5.33M under a trading plan, leaving 551,683 shares. Filed Nov 2, 2026 (Form 4).
- Sold
- 30,881 shares
- Price
- US$172.57 average (US$167.40 to US$175.25)
- Value
- US$5.33M
- Holding after
- 551,683 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chairman & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | Common Stock | Option exercise | 15,881 | US$72.34 | 582,564 | Direct |
| Oct 30, 2026 | Common Stock | Sale | 15,881 | US$175.25 | 566,683 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 1,600 | US$167.40 | 565,083 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 1,700 | US$168.10 | 563,383 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 1,904 | US$169.27 | 561,479 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 7,796 | US$170.35 | 553,683 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 2,000 | US$171.06 | 551,683 | Direct |
Source
Download original · View original at SEC
Related
- Gilead Sciences, Inc.
- O'Day Daniel Patrick
- Gilead Sciences, Inc. shareholders
- Form 4 · O'Day Daniel Patrick · Nov 6, 2026
- Form 4 · O'Day Daniel Patrick · Oct 2, 2026
- Form 4 · O'Day Daniel Patrick · Sep 11, 2026
- Form 4 · O'Day Daniel Patrick · Sep 2, 2026
- Form 4 · O'Day Daniel Patrick · Aug 4, 2026
- Form 4 · Mercier Johanna · Nov 17, 2026
- Form 4 · Dickinson Andrew D · Nov 17, 2026
- Form 4 · Kramer Kelly A. · Nov 16, 2026
- Form 4 · Cain Wettan Keeley M · Nov 9, 2026
- Form 4 · Mercier Johanna · Oct 16, 2026